4-aminopyridine has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisseling, TM | 1 |
Versteegen, MG | 1 |
van der Wal, S | 1 |
Copius Peereboom-Stegeman, JJ | 1 |
Borggreven, JM | 1 |
Steegers, EA | 1 |
van der Laak, JA | 1 |
Russel, FG | 1 |
Smits, P | 1 |
Troncoso Brindeiro, CM | 1 |
Fallet, RW | 1 |
Lane, PH | 1 |
Carmines, PK | 1 |
2 other studies available for 4-aminopyridine and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus.
Topics: 4-Aminopyridine; Charybdotoxin; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Glyburide; Hum | 2005 |
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.
Topics: 4-Aminopyridine; Animals; Apamin; Arterioles; Bee Venoms; Diabetes Mellitus, Experimental; Diabetes | 2008 |